Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for KOMBINATION AUS EINEM PD-1-ANTAGONISTEN UND EINEM VEGFR-INHIBITOR ZUR BEHANDLUNG VON KREBS
Details for 2015703439
Up to date per 13.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2015703439
Title / Product Name
KOMBINATION AUS EINEM PD-1-ANTAGONISTEN UND EINEM VEGFR-INHIBITOR ZUR BEHANDLUNG VON KREBS
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2015703439
EP Publication Number
3102605
E-Number
1064700
Language
EN
PCT Number
US15014212
Publication Date
14.12.2016 A
14.11.2018 B1
Registration Date
14.11.2018
AT Publication Date
15.11.2018
Application Date
03.02.2015
Registration Number
-
Priorities
04.02.2014
US
201461935809 P
IPC
C07K 16/28 20060101AFI20150820BHEP
Maximum Duration of Protection
03.02.2035
Owner
Pfizer Inc.
66 Hudson Boulevard East
New York, NY 10001-2192
US
Merck Sharp & Dohme LLC
126 East Lincoln Avenue, P.O. Box 2000
Rahway, New Jersey 07065
US
Representative
Representative
Schwarz & Partner Patentanwälte GmbH
Wipplingerstraße 30
1010 Wien
AT
Inventor
MARTINI, Jean-francois, Andre
7420 Circulo Sequoia
Carlsbad, CA 92009
US
TARAZI, Jamal, Christo
10867 Pesos Place
San Diego, CA 92124
US
PERINI, Rodolfo, Fleury
707 Captains Way
Philadelphia, PA 19146
US
MAURO, David, J.
351 North Sumneytown Pike
North Wales, PA 19454
US